NEW YORK (GenomeWeb) – GeneNews has announced a C$5 million ($3.9 million) capital commitment agreement with Global Emerging Markets (GEM) Global Yield Fund.

Under the terms of the agreement, GeneNews has the right, but no obligation, to draw funds for a term of three years. Common shares will be issued to GEM at a price per share equal to either the floor price set by GeneNews or a 10 percent discount to the market price of common shares based on the immediately preceding five-day volume-weighted average price, whichever is higher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.